Amcor trims transition-period earnings outlook as energy and freight costs weigh on quarter
The packaging group reported 7% higher quarterly sales of $6.13bn but lowered its adjusted EPS guidance, citing the timing of cost pass-through.
Amcor plc reported results on 4 November 2026 for the quarter ended 30 September 2026. Net sales were $6,129 million, up 7%. GAAP diluted earnings per share were $0.52, while adjusted EPS came in at $0.95.
The company lowered its adjusted EPS outlook for the six-month transition period to a range of $1.70 to $1.80, from $1.80 to $1.90 previously. It attributed the cut to the timing of passing through higher energy and distribution costs.
Amcor also declared a quarterly dividend of 66.0 cents per share. The material available to VigiEye gave no further detail, such as segment performance or payment dates.
Amcor is a packaging manufacturer, not a drug company, so the announcement is financial rather than regulatory in nature.
What it means for your team
- Packaging suppliers are reporting that higher energy and distribution costs reach customers with a lag. Procurement and market-access teams may want to ask about the timing of any pass-through.
- The source gives no pharmaceutical-specific figures or supply commentary, so it does not point to any change in medicine packaging supply.
- Quality and supply-chain teams may wish to check supplier contracts for how cost adjustments are applied.
Company's press release (SEC filing): Amcor plc ↗
Article written by VigiEye from the official source (Amcor plc). Claims are the company's own. AI-assisted; check the source before acting.